Alcon Inc. announced December 15 that its board of directors approved a merger agreement with Novartis AG, whereby Novartis will pay a total merger consideration valued at $168 per share for the Alcon ...

Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, will be acquired by Alcon, the world’s largest eye-care devices company, for about $770 million following a definitive ...

The eye-care company Alcon Research has entered into licensing and purchase option agreements with Potentia Pharmaceuticals to develop Potentia's leading drug candidate — a complement pathway ...

Medical device peers Alcon, Cooper Cos. and Johnson & Johnson own 25% to 40% of the market for contact lenses vs. 10% for Bausch + Lomb. In pharmaceuticals, AbbVie would encounter antitrust ...

Tarsus Pharmaceuticals (NASDAQ:TARS) has pared some of an earlier gain of as much as 13% and is now up 8% amid a report that ...

Alcon, which has been dedicated to the ophthalmic industry for 60 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Forte Biosciences (FBRX – Research Report) and ...

MARGAO: Alcon GSB Unity Cup 2025, a T20 cricket tournament, organised by the GSB Sports and Charitable Trust in collaboration with the Goa Saraswat Samaj, will ...